Cdk2 (0.N.198) Antibody sc-70829 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCdk2 (0.N.198) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-70829
NCBI Gene Aliasesp33(CDK2), CDKN2, A630093N05Rik
Antibody TypePrimary Antibodies
Clone0.N.198
Quantity200 µg/ml
Reactivitymouse, rat, human
ApplicationsWB, IP
ClonalityMonoclonal
Conjugate/TagUnconjugated
Hostmouse
FormatPurified
NCBI Full Gene Namecyclin dependent kinase 2
TargetCdk2
IsotypeIgG2a

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cellsThoracic cancerJune 1, 2020Chen R, Chen Y, Yuan Y, Zou X, Sun Q, Lin H, Chen X, Liu M, Deng Z, Yao Y, et al.

(2) Deoxypodophyllotoxin inhibits cell viability and invasion by blocking the PI3K/Akt signaling pathway in human glioblastoma cellsOncology reportsApril 1, 2019Wang W, Gao W, Zhang L, Zhang D, Zhao Z, Bao Y.

(3) Inhibitory effects of Schisandrin B on human prostate cancer cellsOncology reportsJanuary 1, 2019Nasser MI, Han T, Adlat S, Tian Y, Jiang N.Sc‑8396), cyclin A (1:1,000; cat. no. 271682), cyclin E (1:1,000; cat. no. Sc‑48420), CDK2 (1:500; cat. no. Sc‑70829), mouse (1:500; cat. no. Sc‑2791), anti‑rabbit (1:1,000; cat. no. Sc‑2774) and p53 (1:1,000; cat. no.

(4) MicroRNA-1254 exerts oncogenic effects by directly targeting RASSF9 in human breast cancerInternational journal of oncologyNovember 1, 2018Li B, Chen P, Wang J, Wang L, Ren M, Zhang R, He J.(sc-8312, 1:2,000), mouse monoclonal anti-Cyclin D1 (sc-70899, 1:1,000), mouse monoclonal anti-CDK2 (sc-70829, 1:1,000), rabbit polyclonal anti-p53 (sc-6243, 1:1,000) and mouse monoclonal anti-β-actin (sc-58673,

(5) Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathwayMolecular medicine reportsJanuary 1, 2018Zhao X, Zhou D, Liu Y, Li C, Zhao X, Li Y, Li W.TX, USA), p21 (1:500; cat. no. sc‑136020; Santa Cruz Biotechnology, Inc.), CDK2 (1:1,000; cat. no. sc‑70829; Santa Cruz Biotechnology, Inc.), FAK (1:200; cat. no. sc‑271195; Santa Cruz Biotechnology, Inc.), SRC

(6) Anticancer effects of an extract from the scallop Patinopecten yessoensis on MCF-7 human breast carcinoma cellsOncology lettersAugust 1, 2017Lee C, Chun W, Zhao R, Kim YD, Nam MM, Jung DH, Cho IJ, Jegal KH, Lee TH, Kim YW, et al.directed against Actin (cat. no. sc-58673), Bcl-2 associated X (Bax) (cat. no. sc-7480), Cdk2 (cat. no. sc-70829), and Cdk4 (cat. no. sc-136241) were obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA).

(7) CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesisClinical cancer research : an official journal of the American Association for Cancer ResearchAugust 1, 2010Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, et al.

(8) Stanniocalcin 1 and ovarian tumorigenesisJournal of the National Cancer InstituteJune 2, 2010Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH, Liu J.

Be the First to Write a Review!

Cdk2 (0.N.198) Antibody

Cdk2 (0.N.198) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (8)

Reviews

Cdk2 (0.N.198) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map